People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Jabez Biosciences, Inc. | — | Biotechnology | Seed | $1.6M | $993K | 2024 |
| Nok Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $817K | $977K | 2024 |
Martin Lewis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Martin Lewis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Lewis | 2 | 12 |
| Robert Lewis | 2 | 6 |
| David Mehalick | 2 | 5 |
| Bruce Cassidy | 2 | 5 |
| Brian Cogley | 2 | 3 |
| Tamara Jovonovich | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.